Introduction
Mitochondrial (mt) DNA mutations are known to be associated with a variety of human diseases. More than 100 different pathogenic mutations have so far been reported, 58% of which reside in tRNA genes (1) (2) (3) . Functional analysis of mt tRNAs with such mutations will thus be necessary to clarify the molecular pathogenesis of mitochondrial diseases. If a mutation does not affect replication of mt DNA or transcription of the corresponding mt tRNA, its deleterious effect in the mt tRNA gene can be assigned to the post-transcriptional level -including maturation, modification, folding, stability, aminoacylation, association with translation factors, and /or various functions on the ribosome.
A novel taurine-containing uridine modification was recently identified (4), which was found to be absent in two mutant mt tRNAs: tRNA Leu(UUR) with either an A3243G maturation in mitochondria. In human mitochondrial DNA, the CCA sequence of tRNAs is not encoded in the tRNA genes but is post-transcriptionally synthesized by ATP (CTP):tRNA nucleotidyltransferase (CCA-adding enzyme). We recently cloned and characterized the human mt CCA-adding enzyme, and showed that it efficiently recognizes mt tRNAs with unusual structures (8) . Bacterial and yeast CCA-adding enzymes have been shown to recognize the elbow-region of tRNA formed by D-and T-loop interaction (9) (10) (11) . In contrast, human mt tRNAs have no consensus sequence in either the D-or T-loop. Although the tRNA recognition mechanism of the human mt CCA-adding enzyme is now under investigation, the T-arm has been found to be important for efficient CCA-addition (8) .
We report here in vitro evidence that two pathogenic mitochondrial point mutations significantly inhibit CCA-addition to the corresponding tRNAs. The first mutation, A4317G in the mt tRNA Ile gene, was described to be associated with severe cardiomyopathy in a 1-year-old infant who died from cardiac failure (12). The other, A10044G in the mt tRNA Gly gene, was reported in several siblings of one family and appeared to be associated with sudden unexpected death (13). Although little is known of the molecular pathogenesis of these two point mutations, since they occur at similar positions in the respective T-loops of mt tRNA Ile and tRNA Gly , we speculated that the y could modulate CCA-adding activity during the tRNA maturation. A kinetic analysis of CCA-addition and a structural investigation of the mutant tRNAs indicated the involvement of these pathogenic point mutations in the molecular pathogenesis of mitochondrial diseases. (14) . All transcripts obtained were purified by denaturing 12% polyacrylamide gels containing 7 M urea.
Assays of CCA-adding enzyme
Assays were carried out as described previously (8 PAGE and the radioactivity of the labeled bands was measured using an image analyzer (BAS-5000; Fuji Photo Film).
Determination of kinetic parameters for C-addition or A-addition
The 10-µl reaction mixtures for C-addition or A-addition contained 50 mM loaded onto 50-cm-long denaturing 15% polyacrylamide gel containing 7 M urea and 10% glycerol. The gels were exposed to an imaging plate and analyzed with a bioimaging analyzer (FLA3000; Fuji Photo Film).
Conformational analysis of small RNA fragments
Short RNA fragments containing the T-arm region of the wild-type and A4317G after denaturation in a super-denaturing buffer (50% formamide, 1× TBE) at 65°C for being mixed with a denaturing buffer (7 M urea, 1× TBE), and a non-denaturing condition (15% polyacrylamide, 1× TBE) without denaturation.
Measurement of RNA melting profiles
Melting profiles were measured by a Gilford Response II spectrophotometer using 0.1 or 0.2 A 260 units of RNA samples in 400 µl of a buffer consisting of 50 mM sodium cacodylate (pH 7.0), 10 mM MgCl 2 , and 200 mM NaCl as previously described (16) .
Results

Effects of pathogenic A4317G and A10044G mutations in mt tRNAs on CCA-addition
We previously found that the human mt CCA-adding enzyme requires the T-arm region of mt tRNAs for efficient CCA-addition (8), prompting us to hypothesize that some mitochondrial diseases associated with pathogenic point mutations in tRNA genes may result from an absence or an inefficiency of CCA-addition to mt tRNA during maturation. Because two pathogenic point mutations, A4317G and A10044G, were found at similar positions in the respective T-loop of mt tRNA Ile and mt tRNA Gly , we focused our attention on evaluating these mutations (Fig. 1) .
To examine the effects of the mutations, we prepared wild-type and mutant tRNAs without the 3′ terminal CCA sequence (tRNA-D) by in vitro transcription, and evaluated their capability of incorporating CCA catalyzed by the recombinant human mt CCA-adding enzyme (8) . As shown in Fig. 2a (Fig. 2a) .
Since the CCA-adding reaction consists of C-addition and A-addition, we prepared wild-type and mutant tRNAs without the 3′ terminal CA sequence (tRNA-DC) and 3′ terminal A (tRNA-DCC), and investigated the efficiency of C-addition to tRNA-DC and A-addition to tRNA-DCC. Both C-and A-addition to mutant tRNAs were reduced (Fig. 2b) , not as remarkably as the entire CCA-addition (Fig. 2a) ,
suggesting that the reduced reaction at each step of C-and A-addition accumulatively results in significant decrease of whole CCA-addition (Fig. 2a) The kinetic parameters of C-addition to tRNAs-DC and A-addition to tRNAs-DCC for wild-type and mutant tRNAs were determined as shown in Table I . The k cat values for both mutant tRNAs were severely reduced, whereas K m values were slightly affected in either C-or A-adding step. This observation suggests that these two mutations inhibit both C-and A-adding steps by mainly hindering the catalytic process without affecting the substrate recognition.
Structural rearrangement of T-arm in mt tRNA Ile with the A4317G mutation
Suspecting that the reduction in the k cat value might arise from structural alteration caused by the pathogenic point mutation, we carried out nuclease probing using double-stranded specific RNase V1 and single-stranded specific cleavages by nuclease S1 and RNase U2, and compared the cleavage profiles with those of the wild type. The nuclease cleavage pattern in Fig. 3a indicates that while the A4317G mutant appears to retain the global secondary structure of the wild-type mt tRNA Ile , some significant differences are evident in the T-arm region. C54 and C62 of the the A4317G mutant became sensitive to double-strand ed specific RNase V1 on the 5′ side, while the 5′ side of A49 exhibited high resistibility to this nuclease (Fig. 3b) . This finding suggests structural rearrangement of the T-arm region caused by the A4317G mutation, as was predicted by Tanaka 
Aberrantly stable secondary structure of T-arm in mt tRNA Ile induced by the A4317G mutation
The structural rearrangement by the A4317G mutation is supported by the abnormal migration of RNA fragments containing the T-arm region on the alk aline ladder (Fig. 3a) . The 3′ part of the RNA fragment cleaved at the 3′ side of A49 of the mutant tRNA migrates faster than the corresponding fragment of the wild type, while normal migration of a one-nucleotide-short RNA fragment (cleaved at the 3′ side of G50) is observed. This extraordinary mobility of the RNA fragment of the mutant tRNA, in spite of the electrophoresis of the denaturing gel at 55°C, suggests the formation of aberrantly stable secondary structure in the T-arm region caused by the A4317G mutation. Similar faster migration is observed in the cases of RNA fragments corresponding to positions 45-48, indicating that the stable secondary structure of the T-arm region is retained in the whole tRNA molecule with the A4317G mutation.
To characterize the structural rearrangement resulting from the A4317G mutation, the 3′ parts of RNA fragments from G50 to A73 with or without the mutation were synthesized by T7 RNA polymerase (Fig. 4a) . Figure 4b shows that the RNA fragment with the A4317G mutation migrated faster than the wild type in gels under the non-denaturing or regular denaturing condition (as in Fig. 3a) , while no discernable difference in the mobility was observed in the super-denaturing gel (see Materials and methods for details of each condition). Faster migration in the gel is indicative of a stable, compact structure of the RNA fragment with the A4317G mutation
The melting profiles of the wild type and mutant fragments are plotted in Fig. 5a .
Only the mutant fragment exhibits an evident melting curve with higher Tm value, verifying its stable secondary structure. This also explains the fact that the Tm value of mt tRNA Ile with the A4317G mutation (59°C) was higher than that of the wild-type mt tRNA Ile (57.5°C) (Fig. 5b) .
Taken together, these results demonstrate that the strong inhibition of A10044G mutant was also evaluated by nuclease probing (Fig. 6a) . As shown in Fig. 6b , strong cleavages were observed at both the 5′ and 3′ sides of A55/A56 in the T-loop of the mutant tRNA by nuclease S1 and RNase U2, respectively. In addition, residues in the D-loop show slightly higher sensitivity to nuclease S1, with decreased accessibility at the 5′ side of U20/A21 by RNase V1. These results suggest that tertiary interaction between the T-and D-loops is weakened by the A10044G mutation, whereas the global secondary structure is conserved.
Discussion
In the initial step of mammalian mitochondrial tRNA maturation process, the 5′-end leader and 3′-end trailer are removed by RNase P and 3′-tRNAse, respectively, followed by the addition of 3′ CCA terminus by the CCA-adding enzyme (18, 19) . It is possible to consider that some pathogenic mutations may have deleterious effect on the tRNA maturation step. Here, we have shown that both the A4317G and A10044G mutations in mt tRNAs significantly inhibit the CCA-addition by the human mt CCA-adding enzyme.
Both C-and A-addition were inhibited by these mutations, not as remarkably as the entire CCA-addition, suggesting that the reduced reaction at two C-adding steps and one A-adding step accumulatively results in significant decrease of whole CCA-addition.
The CCA sequence of mt tRNAs is not encoded in the tRNA genes but is post-transcriptionally synthesized by mt CCA-adding enzyme. Immature tRNAs without complete CCA sequence cannot be aminoacylated nor protected by elongation factors, resulting in their instability in mitochondria. Thus, the significant decrease of entire CCA-addition by A4317G and A10044G mutations (Fig. 2a) might be a direct cause for mitochondrial dysfunction.
The A4317G mutation in mt tRNA Ile induced a structural rearrangement of the T-arm region, while the A10044G mutation in mt tRNA Gly weakened the T-loop/D-loop interaction. It has been considered that the CCA-adding enzyme recognizes the elbow region of tRNA formed by the D-and T-loops (9, 10, 20, 21) , and we previously showed that the mt CCA-adding enzyme has a lower substrate specificity than the E. coli enzyme -presumably to enable it to recognize mt tRNAs with unusual structures (8).
Our finding that both the A4317G and A10044G mutations in human mt tRNAs had reported the A4317G mutation in mt tRNA Ile , they deduced that it would cause structural rearrangement of the T-arm region (Fig. 3b) (12). Our findings based on nuclease probing and RNA fragment analysis have clearly demonstrated their proposed structural rearrangement. We previously analyzed another pathogenic point mutation -A4269G in mt tRNA Ile associated with fatal cardiomyopathy -and found that this mutation destabilizes the whole tRNA structure with a lower Tm, which explains the rapid decay of the A4269G mutant tRNA observed in cybrid cells (16) . In contrast, the A4317G mutation stabilizes tRNA by forming an aberrantly stable secondary structure in the T-arm region, thereby increasing its Tm value. It is plausible that this structural rearrangement affects various steps in the tRNA maturation process, including CCA-addition. In the case of the A10044G mutation in mt tRNA Gly , such structural rearrangement was not observed, but instead a weakened interaction between the T-and D-loops was suggested. In mitochondria, high sensitivity to nucleases in either the T-or D-loop can lead to instability of the tRNA.
The A4317G mutation was reported to significantly decrease isoleucylation (23, 24) .
Thus, it can be assumed that the pathogenic A4317G mutation at least causes defects in both CCA-addition and the following aminoacylation. In addition, because certain mutations in the T-loop were demonstrated to decrease the tRNA processing activity of Drosophila RNase P and 3′-tRNAse (25) , it can be speculated that both the A4317G and A10044G mutations also affect the 5′-and 3′-processing of tRNA. We cannot define which step in tRNA maturation process is the most damaged in vivo, since neither of the cell lines carrying these mutations is available at the present time (Tanaka et al., personal communication). Even if the 5′-and 3′-processing proceeds inefficiently by these mutations, the following CCA-addition and aminoacylation are still considered to be crucial steps for tRNA function.
Our findings presented here indicate the probability that the CCA-addition disorder of the pathogenic A4317G and A10044G mutants is involved in mitochondrial dysfunction. Furthermore, they suggest an approach to understanding the mechanism of tRNA recognition by the mt CCA-adding enzyme, which is currently under investigation.
laboratory facilities and for his continuous encouragement during this project. We also thank Drs. Kozo Tomita and Nono Takeuchi (Univ. of Tokyo) for many technical advices and helpful discussions. 
tRNA Gly tRNA Ile 
